arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

BELITE BIO, INC

BLTE
$142.81 ▼ -10.99 (-7.15%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
7 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Neutral
auto_awesome

Analytical Summary

BELITE BIO, INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book 7.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

Health Breakdown

Returns
34
Financial Health ↓
0
Cash Quality ↓
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 7 quarters